Search Results

There are 12352 results for: content related to: Investigation of the haemodynamic effects of exenatide in healthy male subjects

  1. Glucagon-like peptide analogues for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Deepson S. Shyangdan, Pamela Royle, Christine Clar, Pawana Sharma, Norman Waugh and Ailsa Snaith

    Published Online : 5 OCT 2011, DOI: 10.1002/14651858.CD006423.pub2

  2. Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 6, June 2012, Pages: 546–554, M. S. Fineman, K. F. Mace, M. Diamant, T. Darsow, B. B. Cirincione, T. K. Booker Porter, L. A. Kinninger and M. E. Trautmann

    Version of Record online : 10 FEB 2012, DOI: 10.1111/j.1463-1326.2012.01561.x

  3. Once weekly exenatide: efficacy, tolerability and place in therapy

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 10, October 2013, Pages: 871–881, C. Wysham, M. Grimm and S. Chen

    Version of Record online : 24 MAR 2013, DOI: 10.1111/dom.12084

  4. An overview of once-weekly glucagon-like peptide-1 receptor agonists—available efficacy and safety data and perspectives for the future

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 5, May 2011, Pages: 394–407, S. Madsbad, U. Kielgast, M. Asmar, C. F. Deacon, S. S. Torekov and J. J. Holst

    Version of Record online : 24 MAR 2011, DOI: 10.1111/j.1463-1326.2011.01357.x

  5. You have full text access to this Open Access content
    Long-term safety and efficacy of exenatide twice daily in Japanese patients with suboptimally controlled type 2 diabetes

    Journal of Diabetes Investigation

    Volume 2, Issue 6, December 2011, Pages: 448–456, Nobuya Inagaki, Kohjiro Ueki, Ayuko Yamamura, Hitoshi Saito and Takeshi Imaoka

    Version of Record online : 26 JUN 2011, DOI: 10.1111/j.2040-1124.2011.00137.x

  6. Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus

    The Journal of Clinical Pharmacology

    Volume 48, Issue 12, December 2008, Pages: 1389–1399, Dr Prajakti A. Kothare, Dr Helle Linnebjerg, Dr Yoshitaka Isaka, Mr Kazunori Uenaka, Dr Ayuko Yamamura, Dr Kwee Poo Yeo, Dr Amparo de la Peña, Dr Choo Hua Teng, Dr Kenneth Mace, Mr Mark Fineman, Dr Hirofumi Shigeta, Dr Yukikuni Sakata and Dr Shin Irie

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008323750

  7. Application of model-based methods to characterize exenatide-loaded double-walled microspheres: In vivo release, pharmacokinetic/pharmacodynamic model, and in vitro and in vivo correlation

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 10, October 2012, Pages: 3946–3961, Xingang Li, Liang Li, Xipei Wang, Yupeng Ren, Tianyan Zhou and Wei Lu

    Version of Record online : 29 JUN 2012, DOI: 10.1002/jps.23236

  8. You have full text access to this Open Access content
    Improved glycemic control and reduced bodyweight with exenatide: A double-blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks

    Journal of Diabetes Investigation

    Volume 2, Issue 3, June 2011, Pages: 210–217, Takashi Kadowaki, Mitsuyoshi Namba, Takeshi Imaoka, Ayuko Yamamura, Wakana Goto, Marilyn K. Boardman and Hideaki Sowa

    Version of Record online : 10 DEC 2010, DOI: 10.1111/j.2040-1124.2010.00084.x

  9. You have free access to this content
    Exenatide: a review from pharmacology to clinical practice

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 6, June 2009, Pages: 544–556, R. Gentilella, C. Bianchi, A. Rossi and C. M. Rotella

    Version of Record online : 5 APR 2009, DOI: 10.1111/j.1463-1326.2008.01018.x

  10. You have full text access to this OnlineOpen article
    Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy

    International Journal of Clinical Practice

    Volume 66, Issue 12, December 2012, Pages: 1147–1157, G. S. Tobin, M. K. Cavaghan, B. J. Hoogwerf and J. B. McGill

    Version of Record online : 14 OCT 2012, DOI: 10.1111/ijcp.12032

  11. You have full text access to this OnlineOpen article
    Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 6, June 2013, Pages: 485–502, R. Balena, I. E. Hensley, S. Miller and A. H. Barnett

    Version of Record online : 12 NOV 2012, DOI: 10.1111/dom.12025

  12. You have free access to this content
    The extra-pancreatic effects of GLP-1 receptor agonists: a focus on the cardiovascular, gastrointestinal and central nervous systems

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 8, August 2014, Pages: 673–688, J. Seufert and B. Gallwitz

    Version of Record online : 16 JAN 2014, DOI: 10.1111/dom.12251

  13. Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 8, August 2011, Pages: 703–710, K. Y. Thong, B. Jose, N. Sukumar, M. L. Cull, A. P. Mills, T. Sathyapalan, W. Shafiq, A. S. Rigby, C. Walton, R. E. J. Ryder and on behalf of the ABCD nationwide exenatide audit contributors

    Version of Record online : 21 JUN 2011, DOI: 10.1111/j.1463-1326.2011.01393.x

  14. Long-term tolerance and efficacy of adjunctive exenatide therapy on glycaemic control and bodyweight in type 2 diabetes: a retrospective study from a specialist diabetes outpatient clinic

    Internal Medicine Journal

    Volume 44, Issue 4, April 2014, Pages: 345–353, M. J. Carrington, Y.-K. Chan, S. Stewart, B. Sjouke, R. Brazilek and N. Cohen

    Version of Record online : 23 APR 2014, DOI: 10.1111/imj.12377

  15. Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 11, November 2009, Pages: 1068–1079, T. Mittendorf, J. Smith-Palmer, L. Timlin, M. Happich and G. Goodall

    Version of Record online : 3 SEP 2009, DOI: 10.1111/j.1463-1326.2009.01099.x

  16. You have free access to this content
    Site-specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity

    British Journal of Pharmacology

    Volume 163, Issue 2, May 2011, Pages: 399–412, Nian Gong, Ai-Niu Ma, Li-Jie Zhang, Xiao-Su Luo, Yin-Hui Zhang, Michael Xu and Yong-Xiang Wang

    Version of Record online : 18 APR 2011, DOI: 10.1111/j.1476-5381.2011.01227.x

  17. The glucagon-like peptide-1-based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeys

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 10, October 2014, Pages: 910–921, D. Roy, K. D. Chadwick, K. Tatarkiewicz, C. LaCerte, A.-M. Bergholm, T. Brodie, R. S. Mangipudy, D. Parkes, M. J. Graziano and T. P. Reilly

    Version of Record online : 27 APR 2014, DOI: 10.1111/dom.12294

  18. You have free access to this content
    Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 5, October 2012, Pages: 510–524, S. Cornell

    Version of Record online : 21 MAR 2012, DOI: 10.1111/j.1365-2710.2012.01342.x

  19. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 8, August 2013, Pages: 737–749, B. Wang, J. Zhong, H. Lin, Z. Zhao, Z. Yan, H. He, Y. Ni, D. Liu and Z. Zhu

    Version of Record online : 20 MAR 2013, DOI: 10.1111/dom.12085

  20. GLP-1 based therapies: differential effects on fasting and postprandial glucose

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 8, August 2012, Pages: 675–688, M.S. Fineman, B.B. Cirincione, D. Maggs and M. Diamant

    Version of Record online : 13 FEB 2012, DOI: 10.1111/j.1463-1326.2012.01560.x